Literature DB >> 23785227

Presentation and management of herpes zoster (shingles) in the geriatric population.

Kenneth R Cohen, Rebecca L Salbu, Jerry Frank, Igor Israel.   

Abstract

Year:  2013        PMID： 23785227      PMCID： PMC3684190     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  117 in total

Review 1.  Zoster-associated pain and neural dysfunction.

Authors:  Michael C Rowbotham; Karin L Petersen
Journal:  Pain       Date:  2001-07       Impact factor: 6.961

2.  The role of antiviral therapy after the resolution of acute herpes simplex keratitis or acute herpes zoster ophthalmicus.

Authors:  Keith H Baratz
Journal:  Arch Ophthalmol       Date:  2012-01

3.  Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study.

Authors:  Mélanie Drolet; Marc Brisson; Kenneth Schmader; Myron Levin; Robert Johnson; Michael Oxman; David Patrick; Stéphanie Camden; James A Mansi
Journal:  J Pain       Date:  2010-11       Impact factor: 5.820

4.  Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  James M Pellissier; Marc Brisson; Myron J Levin
Journal:  Vaccine       Date:  2007-10-17       Impact factor: 3.641

Review 5.  Herpes zoster: epidemiology, natural history, and common complications.

Authors:  Jeffrey M Weinberg
Journal:  J Am Acad Dermatol       Date:  2007-12       Impact factor: 11.527

6.  The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolite levels.

Authors:  S H Sindrup; C Madsen; K Brøsen; T S Jensen
Journal:  Clin Pharmacol Ther       Date:  1999-12       Impact factor: 6.875

Review 7.  Valacyclovir for the management of herpes viral infections.

Authors:  A Chakrabarty; N J Anderson; R Beutner; S K Tyring
Journal:  Skin Therapy Lett       Date:  2005-02

8.  Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.

Authors:  B S Galer; M C Rowbotham; J Perander; E Friedman
Journal:  Pain       Date:  1999-04       Impact factor: 6.961

9.  History of Varicella Zoster Virus.

Authors:  Martin J Wood
Journal:  Herpes       Date:  2000-10

10.  A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.

Authors:  Robert H Dworkin; Richard L Barbano; Stephen K Tyring; Robert F Betts; Michael P McDermott; Janet Pennella-Vaughan; Gary J Bennett; Erhan Berber; John W Gnann; Carrie Irvine; Cornelia Kamp; Karl Kieburtz; Mitchell B Max; Kenneth E Schmader
Journal:  Pain       Date:  2009-02-04       Impact factor: 6.961
View more
  6 in total

Review 1.  Zoster Vaccine Recombinant, Adjuvanted.

Authors:  Kalvin Stoker; Terri L Levien; Danial E Baker
Journal:  Hosp Pharm       Date:  2018-04-02

2.  Serious and Opportunistic Infections in Elderly Patients With Inflammatory Bowel Disease.

Authors:  Elissa Lin; Kevin Lin; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-11

3.  Pilot Analyses of Interferon Subtype Expression Profiles in Patients with Herpes Zoster or Postherpetic Neuralgia.

Authors:  Yu-Chih Chen; Robert W Figliozzi; Shaochung V Hsia
Journal:  Viral Immunol       Date:  2021-04-15       Impact factor: 2.175

4.  Herpes Zoster Infection in an Immunocompromised Patient: A Case Report and Review of Corticosteroid's Role.

Authors:  Rui Seixas; Filipe Dias; Armindo Ribeiro; Sofia Sobral; Henrique Rita
Journal:  Cureus       Date:  2022-01-03

5.  Social isolation: main dermatosis and the impact of stress during the COVID-19 pandemic.

Authors:  Carolina Soutto Mayor Mangini; Rossana Cantanhede Farias de Vasconcelos; Eduarda Villela Rosa Rodriguez; Isabela Romeu Lorenzon de Oliveira
Journal:  Einstein (Sao Paulo)       Date:  2022-03-25

6.  Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study.

Authors:  João Toniolo-Neto; Eliofotisti Psaradellis; Angela Karellis; Emmanouil Rampakakis; Talita Y Rockett; John S Sampalis; Kelly D Johnson; Homero A Monsanto; Camilo J Acosta
Journal:  Clinics (Sao Paulo)       Date:  2018-07-19       Impact factor: 2.365
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.